Fund Holdings — Sofinnova Investments, Inc.

Total Portfolio Value
$1.36B
Total Bought
$501.30M
Total Sold
$322.83M
Net Transaction
+$178.47M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Gilead Sciences Inc(GILD)0774,227+774,227071,5155.24%+71,515
AbbVie Inc(ABBV)0359,393+359,393063,8644.68%+63,864
Sarepta Therapeutics Inc(SRPT)0428,771+428,771052,1343.82%+52,134
Natera Inc(NTRA)1,550,2801,550,2800196,808245,40917.99%+48,601
Stryker Corporation(SYK)0116,005+116,005041,7683.06%+41,768
Jazz Pharmaceuticals PLC(JAZZ)188,562504,193+315,63121,00862,0914.55%+41,084
Replimune Group Inc(REPL)48,1383,149,522+3,101,38452838,1412.80%+37,613
Alnylam Pharmaceuticals Inc(ALNY)0110,157+110,157025,9211.90%+25,921
Alkermes Plc(ALKS)0894,266+894,266025,7191.89%+25,719
Dexcom Inc(DXCM)0290,210+290,210022,5701.65%+22,570
Globus Med Inc(GMED)0244,700+244,700020,2391.48%+20,239
Intuitive Surgical Inc037,896+37,896019,7801.45%+19,780
Boston Scientific Corp(BSX)135,819346,571+210,75211,38230,9562.27%+19,574
Eli Lilly & Co(LLY)014,364+14,364011,0890.81%+11,089
Rhythm Pharmaceuticals Inc(RYTM)276,678397,428+120,75014,49522,2481.63%+7,753
Axsome Therapeutics Inc(AXSM)379,527491,726+112,19934,10841,6053.05%+7,497
Janux Therapeutics Inc(JANX)164,770253,262+88,4927,48613,5600.99%+6,074
Inari Med Inc90,327180,456+90,1293,7259,2120.68%+5,487
Arrivent BioPharma Inc(AVBP)1,696,7521,696,752039,87445,2013.31%+5,328
Soleno Therapeutics Inc586,344757,248+170,90429,60534,0382.49%+4,434
Avantor Inc(AVTR)0200,000+200,00004,2140.31%+4,214
Danaher Corporation(DHR)010,000+10,00002,2960.17%+2,296
Aerovate Therapeutics Inc3,758,6863,758,68607,8569,9610.73%+2,105
AnaptysBio Inc0132,927+132,92701,7600.13%+1,760
Keros Therapeutics Inc(KROS)095,375+95,37501,5100.11%+1,510
ICU Med Inc(ICUI)05,000+5,00007760.06%+776
Enliven Therapeutics Inc034,025+34,02507660.06%+766
Travere Therapeutics Inc(TVTX)032,616+32,61605680.04%+568
Edgewise Therapeutics Inc(EWTX)384,767402,773+18,00610,26910,7540.79%+485
Exact Sciences Corp(EXK)37,63752,042+14,4052,5642,9240.21%+360
Ikena Oncology Inc382,616382,61606626270.05%-34
Pulmonx Corp(LUNG)62,31361,326-9875174160.03%-100
Vir Biotechnology Inc(VIR)129,246114,131-15,1159688380.06%-130
Inhibrx Biosciences Inc(INBX)536,068527,190-8,8788,3958,1190.60%-276
Bolt Biotherapeutics Inc2,754,4372,754,43701,7851,4740.11%-311
Pharvaris N V
COM
600,302560,723-39,57911,11810,7490.79%-369
Erasca Inc(ERAS)1,842,6681,795,880-46,7885,0304,5080.33%-523
Disc Medicine Inc(IRON)41,35222,752-18,6002,0321,4420.11%-590
Immatics N.V366,5680-366,5688520—-852
Astria Therapeutics Inc85,6400-85,6409430—-943
Avidity Biosciences Inc30,47213,789-16,6831,4004010.03%-999
Structure Therapeutics Inc38,79220,892-17,9001,7035670.04%-1,136
Nextcure Inc2,671,8562,671,85603,6602,0600.15%-1,600
Perspective Therapeutics Inc(CATX)120,6320-120,6321,6100—-1,610
Immunome Inc(IMNM)676,766746,824+70,0589,8947,9310.58%-1,963
Immatics N.V(IMTX)386,100343,206-42,8944,4052,4400.18%-1,965
Dyne Therapeutics Inc(DYN)772,0701,071,498+299,42827,73325,2441.85%-2,488
Becton Dickinson & Co(BDX)15,1914,951-10,2403,6631,1230.08%-2,539
Achieve Life Sciences Inc1,514,0321,306,482-207,5507,1774,5990.34%-2,578
Insmed Inc(INSM)286,307256,281-30,02620,90017,6941.30%-3,207
Establishment Labs Hldgs Inc(ESTA)181,47695,305-86,1717,8524,3910.32%-3,462
Thermo Fisher Scientific Inc(TMO)5,7700-5,7703,5690—-3,569
Illumina Inc(ILMN)40,6110-40,6115,2960—-5,296
Vera Therapeutics Inc(VERA)2,793,9872,793,9870123,494118,1588.66%-5,337
Phibro Animal Health Corp(PAHC)238,1840-238,1845,3640—-5,364
Rapport Therapeutics Inc(RAPP)1,995,5941,995,594040,87035,4022.59%-5,468
Kura Oncology Inc(KURA)296,8840-296,8845,8010—-5,801
Syndax Pharmaceuticals Inc(SNDX)786,999658,627-128,37215,1508,7070.64%-6,443
Savara Inc(SVRA)5,662,5505,471,299-191,25124,00916,7971.23%-7,212
Cabaletta Bio Inc(CABA)1,533,8830-1,533,8837,2400—-7,240
Marinus Pharmaceuticals Inc4,386,1770-4,386,1777,7200—-7,720
TG Therapeutics Inc(TGTX)358,6440-358,6448,3890—-8,389
Revolution Medicines Inc(RVMD)203,2710-203,2719,2180—-9,218
Guardant Health Inc(GH)406,6450-406,6459,3280—-9,328
Edwards Lifesciences Corp202,89840,000-162,89813,3892,9610.22%-10,428
Inozyme Pharma Inc4,280,3084,280,308022,38611,8560.87%-10,530
Incyte Corp(INCY)714,176524,267-189,90947,20736,2112.65%-10,996
Y-mAbs Therapeutics Inc2,194,2782,194,278028,85517,1811.26%-11,674
Cogent Biosciences Inc(COGT)2,265,230823,160-1,442,07024,4646,4210.47%-18,044
AstraZeneca PLC(AZN)809,406651,344-158,06263,06142,6763.13%-20,385
IDEAYA Biosciences Inc(IDYA)1,749,4551,069,090-680,36555,42327,4762.01%-27,947
BioAge Labs Inc(BIOA)2,304,9012,304,901047,94213,3450.98%-34,597
Elanco Animal Health Inc(ELAN)3,518,6840-3,518,68451,6890—-51,689
Novo-Nordisk A S(NVO)726,3290-726,32986,4840—-86,484
Page 1 of 1
Sofinnova Investments, Inc. — 13F Holdings — Q4 2024 | TickerTrail